院内心搏骤停前与骤停中预后因素与生存结局的系统综述与Meta分析
该系统综述与Meta分析检索了Medline、PubMed、Embase、Scopus、Web of Science和Cochrane Database of Systematic Reviews(自建库至2019年2月4日),并纳入英国国家心搏骤停审计数据库的未发表原始数据,最终主分析纳入23项队列研究。结果显示,骤停前因素中男性、年龄≥60岁、活动性恶性肿瘤和慢性肾病病史与生存几率降低相关;骤停中因素中目击骤停、监护下骤停、日间发生和初始可除颤心律与生存几率升高相关,而骤停中插管和复苏持续时间≥15分钟与生存几率降低相关。作者结论为,上述因素与院内心搏骤停后生存之间存在中等至高质量证据的关联。
要点
- 初始可除颤心律与院内心搏骤停后生存几率升高相关(OR 5.28, 95%CI 3.78–7.39,高确定性)。
- 目击骤停与生存几率升高相关(OR 2.71, 95%CI 2.17–3.38,高确定性);监护下骤停OR 2.23(95%CI 1.41–3.52,高确定性)。
- 骤停中插管与生存几率降低相关(OR 0.54, 95%CI 0.42–0.70,中等确定性);复苏≥15分钟OR 0.12(95%CI 0.07–0.19,高确定性)。
- 骤停前活动性恶性肿瘤(OR 0.57, 95%CI 0.45–0.71)和慢性肾病病史(OR 0.56, 95%CI 0.40–0.78)与生存几率降低相关,均为高确定性。
- 年龄≥60岁与生存几率降低相关(OR 0.50, 95%CI 0.40–0.62,低确定性);男性OR 0.84(95%CI 0.73–0.95,中等确定性)。
适用人群与场景
- 院内心搏骤停患者,纳入23项队列研究,研究类型为调查骤停前与骤停中预后因素与院内心搏骤停后生存关联的英文研究。
研究设计与关键结果
- 研究类型为系统综述与Meta分析,主分析纳入23项队列研究,数据来源包括Medline、PubMed、Embase、Scopus、Web of Science、Cochrane Database of Systematic Reviews(自建库至2019年2月4日)及英国国家心搏骤停审计数据库的未发表原始数据。
- 骤停前因素:男性OR 0.84(95%CI 0.73–0.95,中等确定性)、年龄≥60岁OR 0.50(95%CI 0.40–0.62,低确定性)、活动性恶性肿瘤OR 0.57(95%CI 0.45–0.71,高确定性)、慢性肾病病史OR 0.56(95%CI 0.40–0.78,高确定性),均与院内心搏骤停后生存几率降低相关。
- 骤停中因素:目击骤停OR 2.71(95%CI 2.17–3.38,高确定性)、监护下骤停OR 2.23(95%CI 1.41–3.52,高确定性)、日间发生OR 1.41(95%CI 1.20–1.66,高确定性)、初始可除颤心律OR 5.28(95%CI 3.78–7.39,高确定性),均与生存几率升高相关。
- 骤停中插管OR 0.54(95%CI 0.42–0.70,中等确定性)、复苏持续时间≥15分钟OR 0.12(95%CI 0.07–0.19,高确定性),与生存几率降低相关。
证据类型、等级与局限
- 证据类型为系统综述与Meta分析,采用GRADE方法评定证据确定性,作者结论为中等至高质量证据支持上述关联。
- 局限:原文未报告局限性。
对床旁实践的改变
- 初始可除颤心律、目击骤停、监护下骤停和日间发生与院内心搏骤停后生存几率升高相关,骤停中插管和复苏≥15分钟与生存几率降低相关,可用于床旁预后沟通。
- 活动性恶性肿瘤、慢性肾病病史、年龄≥60岁和男性与生存几率降低相关,可用于识别生存几率较低的人群。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine associations between important pre-arrest and intra-arrest prognostic factors and survival after in-hospital cardiac arrest.
DESIGN: Systematic review and meta-analysis.
DATA SOURCES: Medline, PubMed, Embase, Scopus, Web of Science, and the Cochrane Database of Systematic Reviews from inception to 4 February 2019. Primary, unpublished data from the United Kingdom National Cardiac Arrest Audit database.
STUDY SELECTION CRITERIA: English language studies that investigated pre-arrest and intra-arrest prognostic factors and survival after in-hospital cardiac arrest.
DATA EXTRACTION: PROGRESS (prognosis research strategy group) recommendations and the CHARMS (critical appraisal and data extraction for systematic reviews of prediction modelling studies) checklist were followed. Risk of bias was assessed by using the QUIPS tool (quality in prognosis studies). The primary analysis pooled associations only if they were adjusted for relevant confounders. The GRADE approach (grading of recommendations assessment, development, and evaluation) was used to rate certainty in the evidence.
RESULTS: The primary analysis included 23 cohort studies. Of the pre-arrest factors, male sex (odds ratio 0.84, 95% confidence interval 0.73 to 0.95, moderate certainty), age 60 or older (0.50, 0.40 to 0.62, low certainty), active malignancy (0.57, 0.45 to 0.71, high certainty), and history of chronic kidney disease (0.56, 0.40 to 0.78, high certainty) were associated with reduced odds of survival after in-hospital cardiac arrest. Of the intra-arrest factors, witnessed arrest (2.71, 2.17 to 3.38, high certainty), monitored arrest (2.23, 1.41 to 3.52, high certainty), arrest during daytime hours (1.41, 1.20 to 1.66, high certainty), and initial shockable rhythm (5.28, 3.78 to 7.39, high certainty) were associated with increased odds of survival. Intubation during arrest (0.54, 0.42 to 0.70, moderate certainty) and duration of resuscitation of at least 15 minutes (0.12, 0.07 to 0.19, high certainty) were associated with reduced odds of survival.
CONCLUSION: Moderate to high certainty evidence was found for associations of pre-arrest and intra-arrest prognostic factors with survival after in-hospital cardiac arrest.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018104795.
参考来源
- Fernando SM, Tran A, Cheng W, et al. Pre-arrest and intra-arrest prognostic factors associated with survival after in-hospital cardiac arrest: systematic review and meta-analysis. BMJ. 2019. PMID: 31801749. doi:10.1136/bmj.l6373
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。